surmount tirzepatide trials once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial surmount-1 trial tirzepatide weight loss
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18









:max_bytes(150000):strip_icc()/GettyImages-1426368585-bc9c6396491b4265a27388c410f8dadc.jpg)













